Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$3.94 - $5.44 $207,638 - $286,688
-52,700 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$7.15 - $12.28 $43,786 - $75,202
-6,124 Reduced 10.41%
52,700 $377,000
Q3 2020

Nov 05, 2020

BUY
$10.01 - $13.75 $15,015 - $20,625
1,500 Added 2.62%
58,824 $628,000
Q2 2020

Aug 12, 2020

BUY
$8.05 - $14.21 $31,604 - $55,788
3,926 Added 7.35%
57,324 $723,000
Q1 2020

May 12, 2020

BUY
$6.8 - $14.66 $64,464 - $138,976
9,480 Added 21.59%
53,398 $489,000
Q4 2019

Jan 27, 2020

BUY
$12.82 - $16.85 $412,675 - $542,401
32,190 Added 274.47%
43,918 $613,000
Q3 2019

Oct 31, 2019

BUY
$16.31 - $28.29 $66,871 - $115,989
4,100 Added 53.75%
11,728 $202,000
Q2 2019

Aug 15, 2019

BUY
$19.18 - $27.88 $146,305 - $212,668
7,628 New
7,628 $208,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $207M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.